{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-094371","form_type":"8-K","ticker":"ANIP","cik":"0001023024","company_name":"ANI PHARMACEUTICALS INC","filed_at":"2023-08-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.910482+00:00","generated_at":"2026-06-11T04:37:44.013772+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"ANI Pharma appoints Matt Leonard to board; Nash not to seek reelection","bullets":["Board appointed Matt Leonard as director, effective August 21, 2023, with term expiring at 2024 annual meeting.","Leonard is Chief Pharmacy Strategy Officer at Capsule; previously held senior roles at CVS Health and Covetrus.","Leonard receives initial restricted stock award of $435,000 vesting over three years under the 2022 Stock Incentive Plan.","David B. Nash will not seek reelection at the 2024 annual meeting; continues as director until then.","Nash's decision not due to any disagreement with the company on operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-094371","json":"https://secwatch.observer/filing/0001104659-23-094371.json","markdown":"https://secwatch.observer/filing/0001104659-23-094371.md","text":"https://secwatch.observer/filing/0001104659-23-094371.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923094371/0001104659-23-094371-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923094371/tm2324374d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T04:37:44.013772+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"28c654ad6d","claim":"David B. Nash departed as Director at ANI PHARMACEUTICALS INC.","evidence_excerpt":"On August 22, 2023, Dr. David B. Nash, M.D. informed the Board of his decision not to seek reelection as a director on the Board at the Company’s 2024 Annual Meeting of Stockholders","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923094371/0001104659-23-094371-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not seeking reelection"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c09f6696ba","claim":"Matt Leonard was appointed as Director at ANI PHARMACEUTICALS INC.","evidence_excerpt":"appointed Matt Leonard to serve on the Board as a director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923094371/0001104659-23-094371-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}